| Product NDC: | 0069-0186 |
| Proprietary Name: | Pamidronate Disodium |
| Non Proprietary Name: | PAMIDRONATE DISODIUM |
| Active Ingredient(s): | 3 mg/mL & nbsp; PAMIDRONATE DISODIUM |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-0186 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078520 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110510 |
| Package NDC: | 0069-0186-01 |
| Package Description: | 10 mL in 1 VIAL (0069-0186-01) |
| NDC Code | 0069-0186-01 |
| Proprietary Name | Pamidronate Disodium |
| Package Description | 10 mL in 1 VIAL (0069-0186-01) |
| Product NDC | 0069-0186 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PAMIDRONATE DISODIUM |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110510 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | PAMIDRONATE DISODIUM |
| Strength Number | 3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |